In March, Johnson & Johnson tapped mobile health tech player Welldoc to incorporate its diabetes management platform into J&J’s latest blood glucose…
Lumendi earned FDA clearance for its endoscope stabilizer that facilitates minimally invasive endoluminal treatments.
Successful clinical trials require bringing together diverse data, drawing meaningful insights and acting on those quickly. Learn how one company did just that…
Philips is selling a majority stake of its lighting business, Lumileds, to Apollo Global Management for $2 billion, including debt.
The Senate has passed the 21st Century Cures Act, meaning legislation that will reshape medical device regulation is now a signature away passing into law.
After looking into a local Medtronic unit for monopolistic activities, Chinese regulators are charging the company 118.5 million yuan ($17.2 million).
French digital health player Voluntis snagged a CE mark and FDA clearance for its management device for Type 2 diabetics who are treated with basal insulin.
Invendo Medical has received a CE mark for a single-use colonoscope it pitches as a way to eliminate the risk of cross-contamination between procedures.
Abbott secured a CE mark for its portable blood analyzer, which rapidly performs blood tests using two or three drops of blood.
Neurometrix has received a CE mark for the over-the-counter version of its wearable nerve-stimulating device for chronic pain.
Diagnostics player Creavo Medical picked up a CE mark for its battery-powered, portable scanner to help emergency room staff quickly assess heart problems in…